Columbia Care completes acquisition of Green Leaf Medical
On June 11, 2021, Columbia Care Inc. (“Columbia Care”) announced that it completed its acquisition of Green Leaf Medical, LLC (“Green Leaf”).
Total upfront consideration for the transaction was approximately US$240 million, comprised of US$45 million in cash and US$195 million through the issuance of 43,900,144 common shares in Columbia Care, with the potential for additional performance-based milestones in 2022 and 2023.
Following the close of two acquisitions that established Columbia Care as a market leader in the two largest cannabis markets in the world, California and Colorado, the acquisition of Green Leaf expands Columbia Care’s operational scale and footprint in four key, limited license markets by materially enhancing the scale and capabilities of its seed-to-sale operations.
Further information can be found on Business Wire’s website.
Columbia Care is one of the largest and most experienced cultivators, manufacturers and providers of medical and adult use cannabis products and related services with licenses in 18 US jurisdictions and the EU.
Green Leaf is one of the largest private multi-state operators in the United States and a market leader in the mid-Atlantic region with cultivation, extraction, processing, and retail operations across its four-state footprint.